Immunitybio Inc. Earnings

Immunitybio Inc.’s revenue jumped 2423.88% since last year same period to $26.43Mn in the Q2 2025. On a quarterly growth basis, Immunitybio Inc. has generated 59.99% jump in its revenue since last 3-months.

Immunitybio Inc.’s net profit jumped 31.22% since last year same period to $-92.56Mn in the Q2 2025. On a quarterly growth basis, Immunitybio Inc. has generated 28.61% jump in its net profits since last 3-months.

Immunitybio Inc.’s net profit margin jumped 97.27% since last year same period to -350.26% in the Q2 2025. On a quarterly growth basis, Immunitybio Inc. has generated 55.38% jump in its net profit margins since last 3-months.

Immunitybio Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.11 - a 1.82% jump from last quarter’s estimates.

Immunitybio Inc.’s earning per share (EPS) estimates for the current year stand at -0.11.

Immunitybio Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Immunitybio Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.